The building blocks of successful translation of proteomics to the clinic.

The building blocks of successful translation of proteomics to the clinic.
复制标题

DOI:
10.1016/j.copbio.2017.12.011
复制
发表时间:
2018-06
影响因子:
7.7
通讯作者:
Hood L
Hood L
中科院分区:
工程技术1区
文献类型:
--
作者:
Kearney P;Boniface JJ;Price ND;Hood L

文献摘要

参考文献

被引文献

相似文献

最近,使用选择性反应监测(SRM-MS)质谱的前两种多重检测已进入临床实践。尽管肺癌和早产的适应症、风险分层不同,但它们在开发策略中有多个步骤。在这里,我们回顾这些策略及其对生物标志物成功转化为临床实践的影响。我们认为,用于鉴定疾病表型的血液蛋白质组的鉴定现在是一个可重复的标准(尽管复杂)过程。
Recently, the first two multiplexed tests using selective reaction monitoring (SRM-MS) mass spectrometry have entered clinical practice. Despite different areas of indication, risk stratification in lung cancer and preterm birth, they share multiple steps in their development strategies. Here we review these strategies and their implications for successful translation of biomarkers to clinical practice. We believe that the identification of blood protein panels for the identification of disease phenotypes is now a reproducible and standard (albeit complex) process.
DOI: 10.1007/s00408-015-9800-0
发表时间: 2015-12
期刊: Lung
影响因子: 5
作者:
Vachani A;Hammoud Z;Springmeyer S;Cohen N;Nguyen D;Williamson C;Starnes S;Hunsucker S;Law S;Li XJ;Porter A;Kearney P
通讯作者: Kearney P
DOI: 10.1373/clinchem.2009.127514
发表时间: 2010-02
期刊: Clinical chemistry
影响因子: 9.3
作者:
Ellington AA;Kullo IJ;Bailey KR;Klee GG
通讯作者: Klee GG
DOI: 10.1371/currents.rrn1249
发表时间: 2011-07-21
期刊: PLoS currents
影响因子: --
作者:
Ishibe, Naoko;Schully, Sheri;Ramsey, Scott David
通讯作者: Ramsey, Scott David
DOI: 10.1177/153303461000900204
发表时间: 2010-04
影响因子: 2.8
作者:
Eddy JA;Sung J;Geman D;Price ND
通讯作者: Price ND
DOI: 10.1016/j.nbt.2011.11.016
发表时间: 2012-06-15
期刊: NEW BIOTECHNOLOGY
影响因子: 5.4
作者:
Gold, Larry;Walker, Jeffrey J.;Williams, Stephen
通讯作者: Williams, Stephen